autoimmune disease economics
36% Cost Cut in Chronic Disease Management With Biologics
Biologics can slash chronic disease management costs by up to 36%, delivering both fiscal relief and better health outcomes. The savings stem from fewer hospitalisations, improved adherence and more efficient drug use across autoimmune conditions. Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice.